Status:
COMPLETED
Uterotonics for Severe Preeclampsia
Lead Sponsor:
Assiut University
Conditions:
Preeclampsia Severe
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The study compares the effect of Intravenous carbetocin versus combined use of intravenous oxytocin and rectal misoprostol for prevention of postpartum hemorrhage during delivery of women with severe ...
Eligibility Criteria
Inclusion
- Pregnant women which diagnosed with severe pre-eclampsia.
- Singleton pregnancy.
- Termination of pregnancy by Cesarean section after 28 weeks of gestation.
Exclusion
- Suspected or proven placental abruption.
- Known placenta Previa or acreata.
- Multiple pregnancies.
- Obesity (BMI \>35).
- Anemia (\<9 g/dl).
- Retained placental tissues.
- Big baby (\> 4 kg).
- Presence of coagulopathy.
- Polyhydramnios.
- Presence of Uterine fibroids.
- Medical diseases as; cardiac, liver, renal or endocrine diseases.
- General anesthesia.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2021
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT04756661
Start Date
January 1 2020
End Date
February 10 2021
Last Update
February 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut Faculty of Medicine
Asyut, Egypt